Tangent90 is delighted to announce that we have won Gold in the Impact in Pharma Technology category at the PMi Awards 2025 for our work with Alnylam at ESC 2024.
Alnylam’s objective was to communicate with the right HCPs and build relationships. Tangent90’s Resource Centre for Congress helped deliver the experience and evidence.
T90 Team accept the PMi Gold Award
The result was exceptional with all key performance indicators surpassing everyone’s expectations. All interactions, consents and follow-up tasks were instantly distributed to country CRMs for follow-up by local teams, driving return on investment. Alnylam is now rolling out the solution widely.
Judge’s Comments
Alnylam has achieved the goals of many pharma companies at congress:
- making an impression,
- establishing the footprint of the company in a new therapy area, and
- collecting consents in a truly omnichannel way.
This is an impressive use of technology to provide not only instant HCP identification, but a complete ecosystem for consent capture and personalised communication with HCPs; pre-, during, and post-congress.
Judges said the use of joined-up technology and its impact is undeniable. They would love to know more about how KPIs are established because Alnylam has set themselves apart here by executing a project that many companies would aspire to. It has empowered its medical teams to lead confidently, aligning learning with measurable launch readiness impact.
This collaboration has delivered a high-performing, creatively unified and frictionless congress experience that blends seamless CRM integration, real-time content delivery, and strong engagement. Gold winning!
Emma Macleod – Emotive
